MYO's Business Model
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
| Sector & Industry | Healthcare / Medical - Devices |
| Website | https://www.myomo.com |
| CEO (Chief Executive Officer) | Paul R. Gudonis |
| Number of Employees | |
| IPO date | June 12, 2017 |
MYO Latest News
|
|
|
|
|
|
|
|
|
|
| Contact | |
|---|---|
| Country | US |
| Address | 137 Portland Street |
| City | Boston |
| State | MA |
| Phone | 617 996 9058 |
| Zip Code | 02114 |
| Other Identifiers | |
| CIK | 0001369290 |
| ISIN | US62857J2015 |
| CUSIP | 62857J201 |
| Open | 0.8412 |
| Previous Close | 0.8391 |
| Volume | 560.2 Thou. |
| Average Volume | 714.3 Thou. |
| Day’s Range | 0.8202 – 0.9097 |
| 52 Week Range | 0.711-6.44 |
| MA (50) | 0.94166 |
| MA (200) | 1.76428 |
| Market Cap | 33.67 Mil. |
| Shares Out. | 38.44 Mil. |
| Earnings Date | Mar 16, 2026 |
| Beta | |
| Last Dividend | |
| EPS | |
| PE | |
